John Tozzi is a Reporter at Bloomberg News. He covers a range of topics within healthcare, including healthcare administration, patient care, and public health, while also touching on themes of finance and wellness. His work has been featured in various prominent outlets such as Bloomberg-Quint, Fortune, and The Boston Globe.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
John Tozzi's coverage predominantly focuses on the healthcare and pharmaceutical industries, delving into topics such as hospital pricing, mergers and acquisitions, health insurance, and employee power. He provides informed insights through a variety of sources including data citations, press releases, government announcements, and legal policy regulations.
To effectively engage with John Tozzi consider providing expert commentary or insights based on reliable data to support your pitch. Topics related to hospital pricing transparency, industry mergers & acquisitions or regulatory changes in the healthcare sector would be relevant for his coverage. If you have expertise in these areas or access to pertinent data or information that could shed light on these issues it may be valuable to reach out.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: John Tozzi
The largest U.S. health insurer plans to invest $3 billion in AI over 2026 and 2027. UnitedHealth executives say they're seeing a 2-to-1 return, as
At UnitedHealth Group Inc., artificial intelligence reads aloud summaries of medical charts as nurses drive to patients' homes. It listens to millions of customer calls to find the causes of
By: Madison Muller, John Tozzi
As the field of mayoral contenders continues to expand, a new poll released today explains why: Incumbent Brandon Johnson is in weak political shape.
By: John Tozzi, Ike Swetlitz
Brian Evanko, Cigna Group’s new chief executive officer, said he aims to put patients at the center of the company’s strategy. He’ll have to convince people struggling with rising healthcare costs that he’s serious — and persuade Wall Street that this strategy can be profitable.
A review commissioned by UnitedHealth Group Inc. to examine its controversial home visits found a lower error rate than the one that government audits routinely find, part of the company’s effort to rebut criticism of the service.
Merck & Co. won regulatory approval for a pill version of powerful cholesterol medication that Wall Street analysts have said could generate billions of annual sales.
Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to suffer a data breach.
Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to suffer a data breach.
By: David Voreacos, John Tozzi
UnitedHealth Group Inc. board members ignored a raft of governance and oversight risks for years before catastrophic failures triggered billions in losses for investors, a shareholder lawsuit alleges.
By: David Voreacos
UnitedHealth Group Inc. board members ignored a raft of governance and oversight risks for years before catastrophic failures triggered billions in losses for investors, a shareholder lawsuit alleges.
